share_log

Allogene Therapeutics | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement

SEC announcement ·  Oct 15, 2018 16:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more